Literature DB >> 20635308

The role of traditional Chinese herbal medicines in cancer therapy--from TCM theory to mechanistic insights.

W L Wendy Hsiao1, Liang Liu.   

Abstract

Traditional Chinese medicine-based herbal medicines have gained increasing acceptance worldwide in recent years and are being pursued by pharmaceutical companies as rich resources for drug discovery. For many years, traditional Chinese medicines (TCM) have been applied for the treatment of cancers in China and beyond. Herbal medicines are generally low in cost, plentiful, and show very little toxicity or side effects in clinical practice. However, despite the vast interest and ever-increasing demand, the absence of strong evidence-based research and the lack of standardization of the herbal products are the main obstacles toward the globalization of TCM. In recent years, TCM research has greatly accelerated with the advancement of analytical technologies and methodologies. This review of TCM specifically used in the treatment of cancer is divided into two parts. Part one provides an overview of the philosophy, approaches and progress in TCM-based cancer therapy. Part two summarizes the current understanding of how TCM-derived compounds function as anticancer drugs. Georg Thieme Verlag KG Stuttgart-New York.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20635308     DOI: 10.1055/s-0030-1250186

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  108 in total

Review 1.  Drug discovery enters a new era with multi-target intervention strategy.

Authors:  Xiao-ying Tian; Liang Liu
Journal:  Chin J Integr Med       Date:  2012-04-11       Impact factor: 1.978

2.  Curcumin combined with glycyrrhetinic acid inhibits the development of hepatocellular carcinoma cells by down-regulating the PTEN/PI3K/AKT signalling pathway.

Authors:  Mingxiang Chang; Meimei Wu; Hanmin Li
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

3.  The anti-tumor effect and biological activities of the extract JMM6 from the stem-barks of the Chinese Juglans mandshurica Maxim on human hepatoma cell line BEL-7402.

Authors:  Yongli Zhang; Yuqiang Cui; Jiayong Zhu; Hongzhi Li; Jianwen Mao; Xiaobao Jin; Xiangsheng Wang; Yifan Du; Jiazheng Lu
Journal:  Afr J Tradit Complement Altern Med       Date:  2012-12-31

Review 4.  Traditional Chinese medicine: herb-drug interactions with aspirin.

Authors:  Jia Wei Lim; Siow Xian Chee; Wen Jun Wong; Qiu Ling He; Tang Ching Lau
Journal:  Singapore Med J       Date:  2018-05       Impact factor: 1.858

5.  Add-On therapy with Chinese herb medicine Bo-Er-Ning capsule (BENC) improves outcomes of gastric cancer patients: a randomized clinical trial followed with bioinformatics-assisted mechanism study.

Authors:  Boyu Pan; Jingyuan Zang; Jie He; Zhen Wang; Liren Liu
Journal:  Am J Cancer Res       Date:  2018-06-01       Impact factor: 6.166

6.  Krüppel-like factor 4 acts as a potential therapeutic target of Sijunzi decoction for treatment of colorectal cancer.

Authors:  Y Jie; W He; X Yang; W Chen
Journal:  Cancer Gene Ther       Date:  2017-07-28       Impact factor: 5.987

7.  Capilliposide from Lysimachia capillipes inhibits AKT activation and restores gefitinib sensitivity in human non-small cell lung cancer cells with acquired gefitinib resistance.

Authors:  Shi-Rong Zhang; Ya-Si Xu; Er Jin; Lu-Cheng Zhu; Bing Xia; Xu-Feng Chen; Fan-Zhu Li; Sheng-Lin Ma
Journal:  Acta Pharmacol Sin       Date:  2016-11-14       Impact factor: 6.150

8.  Oral Chinese herbal medicine as maintenance treatment after chemotherapy for advanced non-small-cell lung cancer: a systematic review and meta-analysis.

Authors:  Q Wang; Q Wang; S F Wang; L J Jiao; R X Zhang; Y Zhong; J Zhang; L Xu
Journal:  Curr Oncol       Date:  2017-08-31       Impact factor: 3.677

9.  The comparison of miRNAs that respond to anti-breast cancer drugs and usnic acid for the treatment of breast cancer.

Authors:  Demet Cansaran-Duman; Ümmügülsüm Tanman; Sevcan Yangın; Orhan Atakol
Journal:  Cytotechnology       Date:  2020-10-30       Impact factor: 2.058

10.  Identification of the anti-tumor activity and mechanisms of nuciferine through a network pharmacology approach.

Authors:  Quan Qi; Rui Li; Hui-Ying Li; Yu-Bing Cao; Ming Bai; Xiao-Jing Fan; Shu-Yan Wang; Bo Zhang; Shao Li
Journal:  Acta Pharmacol Sin       Date:  2016-05-16       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.